Preoperative treatment with gemcitabine plus nab-paclitaxel is a safe and effective chemotherapy for pancreatic adenocarcinoma Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Antineoplastic Combined Chemotherapy Protocols
  • Neoadjuvant Therapy
  • Pancreatectomy
  • Pancreatic Neoplasms

abstract

  • This data suggests that nab-paclitaxel and gemcitabine is a safe and effective neoadjuvant treatment for potentially resectable pancreatic adenocarcinoma. This promising data should be confirmed in larger, randomized studies.

publication date

  • September 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.ejso.2016.01.006

PubMed ID

  • 26899943

Additional Document Info

start page

  • 1394

end page

  • 400

volume

  • 42

number

  • 9